Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2005
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1577294A1 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1576039A2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
09/21/2005EP1575930A1 Novel retinol derivative and cosmetic composition comprising the same
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1509511B1 Manufacture of ascorbic acid esters
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005CN1671681A Method for producing maleic anhydride
09/21/2005CN1671680A Compound for treatment of anxiety and methods of preparation and use thereof
09/21/2005CN1671655A Novel phthalamide derivatives
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671472A Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
09/21/2005CN1671470A Titaniun-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1670019A Process for extracting tanshinone
09/21/2005CN1669651A Catalyst for preparing gamma-butyrolactone by normal pressure gas phase hydrogenation of maleic-anhydride and preparation process thereof
09/21/2005CN1219775C Halogen contained aromatic compound
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/20/2005US6946564 3-(p-fluorophenyl)-6-(hydroxymethyl)isobenzofuran oxidized by Manganese dioxide to 3-(p-fluorophenyl)-6-isobenzofurancarbaldehyde
09/20/2005US6946563 Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2188796C Heterocyclylbenzonitriles
09/20/2005CA2097676C 2,2-dimethyl 3[(z)1-propenyl] cyclopropane carboxylic acid and intermediates, and process for its preparation
09/15/2005WO2005085222A1 Liquid crystal compound comprising two condensed and substituted rings
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005085170A1 Ester derivatives of rhein and their therapeutic use
09/15/2005WO2005084803A1 Asymmetric reaction catalyst and process for production of optically active compounds with the same
09/15/2005WO2005084643A1 Crystalline composition containing escitalopram oxalate
09/15/2005WO2005084365A2 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
09/15/2005WO2005072711A3 Method for producing sorbicillactone a
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005055935A3 Cationic substituted benzofurans as antimicrobial agents
09/15/2005WO2005054204A3 Pharmaceutical compounds that regenerate in vivo
09/15/2005WO2005051937A3 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
09/15/2005WO2005039496A3 Inhibitors of cathepsin s
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203112 Bicyclic amides
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005DE102004009185A1 New hygrophorone derivatives useful as biocides, antibiotics, fungicides, enzyme inhibitors, disinfectants or wood preservatives
09/15/2005CA2558198A1 Crystalline composition containing escitalopram oxalate
09/15/2005CA2558082A1 Ester derivatives of rhein and their therapeutic use
09/15/2005CA2557301A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005CA2557260A1 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
09/14/2005EP1574507A2 Furo- and pyrano-naphthoquinones and their use in the treatment of cancer
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572628A1 Isophtalic acid derivatives
09/14/2005EP1572623A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
09/14/2005EP1572612A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
09/14/2005EP1572354A1 Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst
09/14/2005EP1511788B1 Method for producing polytetrahydrofurane with low colour indices
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1218366B1 Method for producing cox-2 inhibitors
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor
09/14/2005CN1668607A Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668580A Aminoacetonitriles derivant for controlling parasite
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/14/2005CN1666986A Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1219021C Process for recovery of low molecular weight phenols, furfural, furfuryl alcohol and/or cellulose or cellulose-rich residues
09/13/2005US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/13/2005US6943243 Control of gene expression in eukaryotic cells
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005CA2122318C Vanadium phosphorous catalysts and process for the selective oxidation of hydrocarbons
09/09/2005WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/09/2005WO2005082877A1 Pyrethroid pesticide
09/09/2005WO2005082876A1 C-5 substituted furanone dipeptide cathepsin s inhibitors
09/09/2005WO2005082842A1 Process for producing optically active citalopram, intermediates therefor, and processes for producing these
09/09/2005WO2005082350A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005CA2557444A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/08/2005US20050197504 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid
09/08/2005US20050197388 Crystalline composition containing escitalopram
09/08/2005US20050197384 water or organic solvent extract of mycelium of Antrodia Camphorata; has central cholinergic agonism, hepatoprotection, anti-inflammation or anti-tumor activity
09/08/2005US20050197378 Cationic substituted benzofurans as antimicrobial agents
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/08/2005US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/08/2005US20050196453 Crystal particles of escitalopram oxalate with a broad particle size suitable for use in direct compression; prior to crystallization comprising at least 0.01% (w/w) of or E- Z-4-(4-dimethylamino--dimethylamino-1-(4-fluorophenyl)-but-1-enyl)-3-hydroxymethyl-benzonitrile; tablets
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 472